Park et al. found that the combination of Tie2 activation and Ang2 inhibition is a potent therapeutic approach for eliciting a tumor microenvironment that favors improved chemotherapeutic drug delivery into tumors [41]. The gene discussed is ANGPT2; the disease is neoplasm.